Olaparib and bevacizumab in frontline maintenance of ovarian cancer: An over reliance in unpowered subgroup analysis of the PAOLA-1 trial?

Abstract

Description

p. 1-5.: tab. p&b.

Citation

PAULINO, Eduardo; MELO, Andreia Cristina de. Olaparib and bevacizumab in frontline maintenance of ovarian cancer: An over reliance in unpowered subgroup analysis of the PAOLA-1 trial? J Gynecol Oncol., v. 31, v. 06, p. 1-5, nov. 2020.

Endorsement

Review

Supplemented By

Referenced By